Medical Costs In Asia March 2016
- Written by iPMI Magazine
- font size decrease font size increase font size

The latest info graphic from Pacific Cross International, looks at medical costs around Asia.
Medical Costs In Asia March 2016
- Thailand treatment of CARDIAC ARREST $38,906 USD
- Malaysia treatment of BENIGN NEOPLASM OVARY $2,338 USD
- Singapore treatment of UNS MALIGNANT NEO ESOPHAGUS $42,833 USD
- Indonesia treatment of ACUTE MYOCARDIAL INFARCTION $22,458 USD
- Vietnam treatment of CATARACT $4,102 USD
- Philippines treatment of CARDIAC ARREST $74,727 USD
- Hong Kong treatment of PATHOLOGICAL FRACTURE VERTEBRAE $90,478 USD
About Pacific Cross International
Pacific Cross International is a holding company for the Pacific Cross International group of companies. The group has provided health insurance in Asia for over 65 years. The companies operating entities are located in Hong Kong, Philippines, Thailand, Indonesia, Vietnam and Cambodia. Pacific Cross International as a group provides health insurance for over 75,000+ people representing 53 nationalities living in 42 countries. In 2014 the group provided travel insurance for 2,642,514 travel days for over 200,000+ people.
Related items
- iPMI Magazine Speaks With Eithan Wolf, CEO, PassportCard Germany
- HCI Group Launches New Modular iPMI Plan, NIMBL Health
- APRIL International Maintains Top IPMI Service Rating For 2nd Consecutive Year
- Trawick International Celebrates 25th Anniversary
- PassportCard
- International Private Medical Insurance Magazine Provider Network Directory February 2023
- International Private Medical Insurance Magazine Provider Network Directory January 2023
- Passportcard's Innovative ASO Solution For Large Customers
- Insurance Industry Unites To Support The People Of Ukraine
- iPMI Magazine Round Table: International Medical Cost Containment Strategies 2022
Latest from iPMI Magazine
- iPMI Magazine Speaks With Eithan Wolf, CEO, PassportCard Germany
- HCI Group Launches New Modular iPMI Plan, NIMBL Health
- APRIL International Maintains Top IPMI Service Rating For 2nd Consecutive Year
- Allianz Partners Continues Growth Trajectory Driven By Travel Rebound
- Allianz Partners Enhances Health Business With New Appointments